Experimental and clinical psychopharmacology
-
Exp Clin Psychopharmacol · Aug 2012
Randomized Controlled TrialIntranasal oxycodone self-administration in non-dependent opioid abusers.
Oxycodone, an opioid with known abuse liability, is misused by the intranasal route. Our objective was to develop a model of intranasal oxycodone self-administration useful for assessing the relative reinforcing effects of opioids and potential pharmacotherapies for opioid use disorders. Healthy, sporadic intranasal opioid abusers (n = 8; 7 M, 1 F) completed this inpatient 2.5-week, randomized, double-blind, placebo-controlled, crossover study. ⋯ Oxycodone dose-dependently increased VAS ratings of positive drug effects (e.g., "like") during sample sessions (p < .05). These reports were positively correlated with self-administration behavior (e.g., "like," r = .65). These data suggest that both procedures are sensitive for detecting the reinforcing properties of intranasal oxycodone and may be used to further explore the characteristics of opioid compounds and potential pharmacotherapies for treatment.
-
Exp Clin Psychopharmacol · Apr 2012
Randomized Controlled TrialCoping style moderates the effect of intranasal oxytocin on the mood response to interpersonal stress.
Recent evidence suggests self-administration of intranasal oxytocin may facilitate social interaction by attenuating the stress response to interpersonal conflict. Currently, no published research has documented whether intraindividual factors moderate the effect of intranasal oxytocin on the emotional response to stress. The aim of the present study was to determine whether coping style moderates the effect of intranasal oxytocin on mood in response to an interpersonal stressor in healthy men and women. ⋯ Follow-up analyses using simple slopes revealed self-administration of intranasal oxytocin reduced anxiety in response to the YIPS relative to the placebo in women high in emotion-oriented coping [b = 4.487, t(91) = 2.09, p < .05], but not in women low in emotion-oriented coping, or men. The results suggest that intraindividual factors modulate the effect of intranasal oxytocin on the affective response to stress. Intranasal oxytocin appears to be particularly beneficial to women who endorse high levels of emotion-oriented coping, who may be vulnerable to the negative impact of stress.
-
Exp Clin Psychopharmacol · Apr 2012
Randomized Controlled TrialEgo depletion increases ad-lib alcohol consumption: investigating cognitive mediators and moderators.
When self-control resources are depleted ("ego depletion"), alcohol-seeking behavior becomes closely associated with automatic alcohol-related processing biases (e.g., Ostafin, Marlatt, & Greenwald, 2008). The current study aimed to replicate and extend these findings, and also to investigate whether the effects of ego depletion on drinking behavior would be mediated by temporary impairments in executive function or increases in impulsivity. Eighty heavy social drinkers (46 female) initially completed measures of automatic approach tendencies (stimulus response compatibility [SRC] task) and attentional bias (visual probe task) elicited by alcohol-related cues. ⋯ Ego depletion had inconsistent effects on measures of executive function and impulsivity, and none of these measures mediated the effect of ego depletion on ad-lib drinking. However, the effect of ego depletion on ad-lib drinking was mediated by self-reported effort in suppressing emotion and thoughts during the manipulation. Implications for the effects of self-control strength on drinking behavior, and cognitive mediators of these effects, are discussed.
-
Exp Clin Psychopharmacol · Dec 2010
Randomized Controlled TrialThe effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence.
The cognitive benefits of modafinil to patients undergoing 7-day inpatient withdrawal from methamphetamine (MA) dependence were examined as part of a double-blind, randomized, placebo-controlled pilot trial. Recent evidence has identified modafinil-related improvements in treatment outcomes for MA-dependent patients; however, the benefits to cognition function, which is critical to treatment success but known to be impaired, has yet to be examined. The first 20 participants recruited to the study were administered either 200 mg of modafinil (once daily) or placebo, and a neuropsychological test battery (including an MA version of the emotional Stroop task) at admission (n = 17) and discharge (n = 14). ⋯ All participants showed a significant attentional bias for MA-related stimuli on the emotional Stroop task. The magnitude of bias predicted both retention in treatment and relapse potential at follow-up but was not significantly ameliorated by modafinil treatment. While nonsignificant, the effect sizes of modafinil-related improvements in executive function and memory were consistent with those found in more robustly powered studies of cognitive benefits in attention-deficit/hyperactivity disorder and schizophrenia, supporting the need for further research.
-
Exp Clin Psychopharmacol · Jun 2010
Randomized Controlled Trial Clinical TrialDifferential effect of codeine on thermal nociceptive sensitivity in sleepy versus nonsleepy healthy subjects.
Basal sleepiness-alertness modulates drug effects. Sleepiness produced by sleep restriction leads to increased nociceptive sensitivity, suggesting opioid analgesia may also be modulated by sleepiness-alertness. This study compared thermal nociceptive sensitivity in sleepy versus nonsleepy participants after codeine or placebo. ⋯ More important, there was a Group x Drug interaction with codeine increasing FWL in the nonsleepy, but not the sleepy, group. These data show the analgesic effects of codeine are diminished in sleepy versus nonsleepy individuals. They suggest clinical differences in response to analgesics are partly explained by basal state of sleepiness-alertness.